U.S. Withdraws from WHO: Impact on Global Health Security and Relations

By João L. Carapinha

January 21, 2025

President Trump has signed an executive order to begin the U.S. withdraws from WHO. The order cites the organization’s mishandling of the COVID-19 pandemic. It also highlights the WHO’s failure to implement necessary reforms and its lack of independence from political influence. Additionally, the order addresses the disproportionate financial contributions required from the U.S. compared to other countries. This move involves stopping U.S. funding and personnel support for the WHO. It also seeks alternative international partners.

The U.S. withdrawal from the WHO is driven by criticisms of its handling of the COVID-19 pandemic and other global health crises. The WHO faces accusations of failing to implement urgent reforms. It is also criticized for being unduly influenced by member states’ politics. The executive order emphasizes disparities in financial contributions. The U.S. contributes significantly more than countries like China, despite China’s larger population. The order revokes previous notifications and orders concerning U.S. involvement with the WHO. It directs government departments to stop funding and recall personnel while seeking new partners.

Background

The U.S. withdraws from WHO is not unprecedented. It was first initiated in 2020 but later retracted. The WHO has faced harsh criticism for its response to the COVID-19 pandemic, a major global health crisis. Health experts warn that this withdrawal could weaken global defenses against infectious diseases and pandemics. It may undo decades of progress in fighting diseases like AIDS, malaria, and tuberculosis.

The U.S. withdrawal from the WHO may compromise global health security. It could diminish U.S. influence and financial support essential for international health initiatives and pandemic preparedness. Stopping U.S. funding could severely affect the WHO’s ability to run global health programs. This might result in gaps in health services and research. The U.S. will need to forge new partnerships to continue supporting global health initiatives. This transition could create instability in global health governance. The withdrawal might also disrupt collaborative research efforts and the sharing of health data, which are critical for developing effective health policies.

Overall, the implications of the U.S. withdrawal from the WHO are extensive. They may have significant consequences for global health security, research, and outcomes.

Reference url

Recent Posts

U.S. withdraws from WHO
     

U.S. Withdraws from WHO: Impact on Global Health Security and Relations

🚨 *What does the U.S. withdrawing from the WHO mean for global health?*
President Trump’s executive order to begin the withdrawal process raises serious concerns about the future of global health security. From financial disparities to a shift in international partnerships, the implications could reshape our collective ability to combat pandemics and health crises.

Dive into our article to understand the potential impacts on health outcomes and the quest for new alliances.

#SyenzaNews #globalhealth #healthcarepolicy

semaglutide NAION risk
    

Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence

🔍 Is semaglutide linked to vision loss?

The European Medicines Agency’s PRAC is currently reviewing the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide-containing medicines, including popular treatments like Ozempic and Wegovy. With recent studies yielding conflicting evidence, this review is crucial for patient safety and the future of these therapies.

Read the full article to understand the implications and what this could mean for healthcare providers and patients alike!

#SyenzaNews #Pharmaceuticals #HealthcarePolicy

cervical cancer screening
        

Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in KwaZulu-Natal

💡 *Are single-visit cervical cancer screenings the key to better health outcomes in high HIV prevalence areas?*
A recent study from KwaZulu-Natal, South Africa reveals that repeat single-visit cervical cancer screening using HPV DNA testing is not only the most effective but also the most cost-effective approach for women living with HIV. This aligns with WHO recommendations for comprehensive cervical cancer elimination strategies.

Explore the insights and implications of this vital research that could transform cervical cancer prevention in resource-limited settings.

#SyenzaNews #HealthEconomics #oncology #GlobalHealth

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.